In this issue:
Dapagliflozin in HFREF, with vs. without diabetes
Model to reduce variability of care for inpatients with HF
Vericiguat in HFREF
Representativeness of PIONEER-HF trial population in real-world HFREF
How to diagnose HFPEF with HFA-PEFF, and validation
Using procalcitonin to guide acute HF management
ACE inhibitors/ARBs and COVID-19 risk
Please login below to download this issue (PDF)